InsidersTradesSigma
Zai Lab Ltd. Stock: price and management transactions · Hong Kong · HKEX
Follow the Zai Lab Ltd. share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. Operating in the Health Care sector, Zai Lab Ltd. has logged 37 reports. Market capitalisation: €18bn. The latest transaction was reported on 10 July 2026 (Other). Among the most active insiders: Du Ying. All data is free.
37
Insider Decl.
0
Thresholds
€7,340
12 ops.
Buy Volume
€29m
12 ops.
Sell Volume
29Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,811 of 26,220 companies
31.1
score / 100
Value31
Quality31
FCF yld-0.9%
Earn yld-1.0%
EV/EBITDA·
ROE-24%
Gross mgn58%
Net mgn-38%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 July 2026
Declarations37 total
17,360 shares@ €0.21340.0002% mcap50.5% of flowShareXHKGHKEX:DA20260703E00072
Ideal exit: 28 Mar 2027 (T+270)
70,400 shares@ €0.20190.0001% mcap100.0% of flowShareXHKGHKEX:DA20260625E00258
223,710 sharesShareXHKGHKEX:DA20260623E00404
Ideal exit: 14 Mar 2027 (T+270)
223,710 sharesShareXHKGHKEX:DA20260623E00700
Ideal exit: 14 Mar 2027 (T+270)
223,710 sharesShareXHKGHKEX:DA20260623E00401
Ideal exit: 14 Mar 2027 (T+270)
223,710 sharesShareXHKGHKEX:DA20260623E00369
Ideal exit: 14 Mar 2027 (T+270)
223,710 sharesShareXHKGHKEX:DA20260623E00396
Ideal exit: 14 Mar 2027 (T+270)
223,710 sharesShareXHKGHKEX:DA20260623E00386
Ideal exit: 14 Mar 2027 (T+270)
17,310 shares@ €0.21100.0% of flowShareXHKGHKEX:DA20260623E00380
Ideal exit: 12 Dec 2026 (T+270)
223,710 sharesShareXHKGHKEX:DA20260623E00362
Ideal exit: 14 Mar 2027 (T+270)
223,710 sharesShareXHKGHKEX:DA20260623E00352
Ideal exit: 14 Mar 2027 (T+270)
25 of 37 declarations
About Zai Lab Ltd.
Zai Lab Ltd. is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on the Hong Kong Stock Exchange.